SQLite Web: event_store.db

Update row 129311 in events

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-18T03:05:05.644967+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:8ffa200090d4aeb8","evidence_event_ids":["evt_03f79786a286"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160360.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160360.txt","company":"Tyra Biosciences, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160360.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_dce15c670c8cd38f","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160360.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:25:49.410060+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"DEF 14A","final_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160360.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160360.txt","source_event_id":"evt_03f79786a286","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEF 14A","fp":"bffc451cfdd4cb54","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-05-28"],"entities":[{"asset_class":"equity","name":"Tyra Biosciences, Inc.","relevance":"high","symbol":"TYRA","type":"issuer_company"},{"asset_class":"regulator","name":"Securities and Exchange Commission (SEC)","relevance":"medium","symbol":"","type":"regulator"}],"event_type":"listing","information_gaps":["The specific agenda items/matters to be voted on are referenced as being 'more fully described in the attached proxy statement,' but the actual items are not included in the provided text.","No prior known state is provided in the prompt, so the 'what changed vs prior known state' cannot be determined from the supplied information.","No financial guidance or financial implications are disclosed in the provided excerpt."],"key_facts":["Tyra Biosciences, Inc. invites stockholders to its Annual Meeting of Stockholders.","The Annual Meeting is scheduled for Thursday, May 28, 2026 at 10:00 a.m. Pacific Time.","The Annual Meeting will be completely virtual and conducted via live webcast, with no physical meeting location.","Stockholders must register at www.proxydocs.com/TYRA to be admitted to the live webcast.","Registration requires a Control Number included in the Notice of Internet Availability of Proxy Materials, the proxy card, or accompanying instructions.","The company elected to furnish proxy materials by providing internet access rather than mailing printed copies, using SEC rules.","Most stockholders will receive a Notice of Internet Availability with instructions to access proxy materials and vote via the Internet.","Stockholders can vote online during the meeting even if they previously submitted a proxy."],"numeric_claims":[{"label":"Annual meeting date","value":"2026-05-28"},{"label":"Annual meeting time (Pacific Time)","value":"10:00 a.m."}],"primary_claim":"Tyra Biosciences, Inc. filed Form DEF 14A for its 2026 annual meeting of stockholders to be held virtually on May 28, 2026 at 10:00 a.m. Pacific Time.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Tyra Biosciences, Inc. filed its DEF 14A proxy statement for its 2026 annual meeting of stockholders. The filing states the meeting will be completely virtual and held on May 28, 2026 via live webcast.","topics":["proxy statement","annual meeting of stockholders","virtual meeting","internet availability of proxy materials"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEF 14A \u00b7 Tyra Biosciences, Inc. \u00b7 Filed 20260417","ticker":"TYRA","tickers":["TYRA"],"title":"TYRA filed DEF 14A","url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160360.txt"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel